4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000176
Director sold 5,000 shares at an average $41.93 ($209,646)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARSHALL B LYNNE Director | 2025-08-06 | Sale 10b5-1 | −4,600 | $41.87 | $192,595 | 86,744 | D |
| PARSHALL B LYNNE Director | 2025-08-06 | Sale 10b5-1 | −400 | $42.63 | $17,051 | 86,344 | D |
| Open-market sales · 5,000 sh · avg $41.93 · $209,646 | |||||||
Loading xslF345X05/edgardoc.xml…